Changes in zinc and manganese concentrations in cisplatin-induced acute kidney injury.

Abstract

Cisplatin (CDDP) is a widely used anticancer drug, but acute kidney injury (AKI) is one of the most important dose-limiting factors. Trace metal elements are present in various concentrations in the body and play an important role in maintaining normal vital functions. However, the relationship between CDDP-induced AKI and trace metal elements is unknown. In this study, we cultured human renal proximal tubular epithelial cells in the presence of CDDP (0, 12.5, 25, 50 μM) and analyzed the concentration of trace elements in medium after 24 h. We found that CDDP significantly increased the concentrations of zinc (Zn) and manganese (Mn) in medium and significantly decreased them in lysate. Therefore, we examined the effects of CDDP (3 mg/kg, i.p.) administration on serum and urinary Zn and Mn concentrations in rats. The results showed that urinary excretion of Zn and Mn increased in CDDP-treated rats 5 days after administration. Also, 5 days after administration, pyknosis, nuclear loss, loss of the brush border membrane, and DNA fragmentation were observed, and serum creatinine and blood urea nitrogen levels were found to be significantly increased. These data suggested that 24-h excretion of Zn and Mn might reflect on CDDP induced nephropathy. Monitoring urinary Zn and Mn excretion may be beneficial in detecting AKI, but further studies are needed for clinical application.

• Authors: Yuko Yamamoto, Yuji Hotta, Natsumi Tomita, Aya Naiki-Ito, Ayae Kitagawa, Urara Kuboshiki, Tamaki Hagita, Misuzu Noda, Akimasa Sanagawa, Tomoya Kataoka, Masahiro Kondo, Yoko Furukawa-Hibi, Satoru Takahashi, Kazunori Kimura
• Journal: Biochemistry and biophysics reports (Biochem Biophys Rep) Vol. 33 Pg. 101422 (Mar 2023) ISSN: 2405-5808 [Electronic] Netherlands
• PMID: 36691436 (Publication Type: Journal Article)
• Copyright: © 2023 The Author(s).